Wantstats
Company ProfilePremium

Autolus Therapeutics PLC

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Autolus Therapeutics PLC - Healthcare showcase

Year Founded & Workforce

2014

Industry

Healthcare

Services

Pipeline Candidates
A

Autolus Therapeutics PLC Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Autolus Therapeutics PLC Overview

Company Headquarters: UK, Europe

Founded: 2014

Company Working: Autolus Therapeutics PLC (Autolus), a biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 for the treatment of multiple myeloma; AUTO4 and AUTO 5 for T cell lymphoma; and AUTO6 and AUTO7 to treat solid tumors. The company functions as a single operating segment, which is the business of developing and commercializing gene therapies.

Strategy

Autolus . aims to be at the forefront of cancer treatment in the coming years by diversifying its product portfolio. Moreover, the company focuses on following value-based and ethical healthcare principles to attract new customers and drive global growth. The company also focuses on collaborations with industry partners having complementary technologies and capabilities to strengthen its position in the market in the upcoming years.

Company Snapshot

$1.2M

Revenue

2014

Founded

UK, Europe

Headquarters

SWOT Analysis

Strengths

  • Works in partnership with healthcare providers
  • Enhanced pipeline product portfolio
  • Worldwide presence
  • Collaborations with academic institutions and industry partners

Weaknesses

  • Issues related to management
  • Operates mainly in US and UK

Opportunities

  • Product launches
  • Approvals

Threats

  • Increasing market competition
  • Political and regulatory environment

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Autolus Therapeutics PLC
    • Pipeline Candidates

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Grant Income rose from USD 1.2 Mn in 2016 to USD 1.4 Mn in 2018.
Autolus Therapeutics PLC — By Business Segment
Series (USD Mn)201620172018
Grant Income1.21.71.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →